SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE) Guy-Young; Kaan-Kavakli; S W-Pipe; Alok-Srivastava; Juliana-Aragao; L A-Menapace; Chuanwu-Zhang; Marja-Puurunen; Marek-Demissie; Gili-Kenet;

GLOBAL COMPARATIVE ANTITHROMBIN-FIELD STUDY: IMPACT OF LABORATORY ASSAY VARIABILITY ON THE ASSESSMENT OF ANTITHROMBIN ACTIVITY MEASUREMENT E Seth-Chhabra; A Sadeghi-Khomami; Mingjie-Liu; Guy-Young; S W-Pipe; MC Ozelo; C Le-Camus; M Toh; SA Lima-Montalvao; Marek-Demissie;